RAPT THERAPEUTICS INC's ticker is RAPT and the CUSIP is 75382E109. A total of 84 filers reported holding RAPT THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 1.12 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $691,535 | -75.7% | 34,926 | -70.5% | 0.13% | -77.3% |
| Q3 2022 | $2,850,000 | -64.8% | 118,463 | -73.3% | 0.58% | -64.4% |
| Q2 2022 | $8,096,000 | -17.0% | 443,619 | 0.0% | 1.62% | +10.7% |
| Q1 2022 | $9,755,000 | -40.1% | 443,619 | 0.0% | 1.46% | -35.8% |
| Q4 2021 | $16,294,000 | -13.8% | 443,619 | -27.1% | 2.28% | +2.6% |
| Q3 2021 | $18,899,000 | -24.0% | 608,663 | -22.2% | 2.22% | -29.9% |
| Q2 2021 | $24,879,000 | +12.1% | 782,593 | -21.7% | 3.18% | +9.7% |
| Q1 2021 | $22,200,000 | +0.2% | 1,000,000 | -10.9% | 2.89% | -9.6% |
| Q4 2020 | $22,164,000 | -50.1% | 1,122,237 | -18.7% | 3.20% | -48.2% |
| Q3 2020 | $44,459,000 | -2.6% | 1,380,704 | -12.2% | 6.18% | -3.5% |
| Q2 2020 | $45,626,000 | – | 1,572,237 | – | 6.40% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ponoi Management, LLC | 1,599,417 | $58,747,000 | 54.16% |
| KPCB XV Associates, LLC | 1,297,063 | $47,641,000 | 37.58% |
| Ponoi II Management, LLC | 145,401 | $5,341,000 | 9.70% |
| Euclidean Capital LLC | 432,900 | $15,900,000 | 9.04% |
| Column Group LLC | 1,402,008 | $51,496,000 | 7.00% |
| AJU IB Investment Co., Ltd. | 99,503 | $3,655,000 | 5.09% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 1,148,321 | $42,178,000 | 4.85% |
| Ghost Tree Capital, LLC | 350,000 | $12,856,000 | 4.61% |
| Velan Capital Investment Management LP | 110,000 | $4,040,000 | 3.14% |
| REGENTS OF THE UNIVERSITY OF CALIFORNIA | 443,619 | $16,294,000 | 2.28% |